Our technical scanner evaluates dozens of indicators across the S&P 500 and Nasdaq 100 each trading day, flagging stocks where bullish signals meaningfully outweigh bearish ones. For 2 September 2026, five names stood out with particularly strong technical setups. Here is what the data — and the latest news — suggests about each of them.
1. Cencora (COR) – 13 technical buy signals
Price: $330.97 (+2.28% on the day)
View the full technical analysis of Cencora
Cencora leads today’s scanner with a perfect 13 bull signals and zero bear signals — the cleanest technical reading across the entire watchlist. The Pennsylvania-based pharmaceutical distributor, which carries a market capitalisation of approximately $65 billion, distributes generic and injectable pharmaceuticals across the United States and internationally. A score of 13-0 is relatively rare and points to broad-based technical strength across momentum, trend, and volume-based indicators simultaneously.
From a fundamental backdrop, the picture has improved notably since mid-year. Following a difficult second quarter in which Cencora missed earnings expectations and trimmed its full-year growth guidance — sending shares to a 52-week low — the stock appears to have stabilised and regained upward momentum. More recent commentary from analysts, including a Morgan Stanley upgrade earlier in the year, has framed pharmaceutical distribution as entering a structurally advantageous period, lending a constructive longer-term narrative to the near-term technical recovery.
Kalkine Media recently highlighted the company’s resilient financial performance and its expanding role across the global healthcare supply chain. While the stock remains well below its late-2025 highs, today’s technical reading suggests the market may be reassessing its trajectory. Investors should monitor upcoming earnings commentary for further evidence of a fundamental turnaround to support the technical signal.
2. Cigna (CI) – 13 technical buy signals
Price: $283.06 (+2.53% on the day)
View the full technical analysis of Cigna
Cigna matches Cencora’s bull signal count at 13, though it carries three bear signals as well — a minor caveat, but one worth noting. The health insurance and pharmacy benefits giant has been attracting renewed attention from both analysts and income-focused investors in recent months. Bernstein raised its price target on the stock in July following a positive outlook on the company’s prospects, and the shares responded accordingly with a notable single-day gain.
Multiple valuation analyses published in recent weeks have suggested that Cigna’s shares appear undervalued relative to earnings, even after a meaningful multi-year gain. The company’s Accredo specialty pharmacy unit and its AI-powered Pharmacy Forward initiative have been cited as key drivers of potential earnings growth going forward. These operational developments provide a degree of fundamental context that investors may wish to weigh alongside the technical signal.
It is also worth noting that Cigna was removed from several Russell growth indices earlier in the year, which can create temporary technical dislocations as index-tracking funds adjust their holdings. If the company’s earnings trajectory continues to improve, a re-rating remains a possibility. As always, the technical signal identifies momentum — it does not guarantee that the momentum is sustained.
3. Corteva (CTVA) – 13 technical buy signals
Price: $87.73 (+3.88% on the day)
View the full technical analysis of Corteva
Agricultural sciences company Corteva rounds out the trio of stocks registering 13 bull signals today, also with three bear signals in the mix. The stock posted one of the stronger daily moves in our top five, gaining nearly 4% on the session. Corteva operates in the seeds and crop protection market — a sector that has faced a mixed environment in recent years, balancing structural demand tailwinds from global food security needs against cyclical headwinds in certain regions and product categories.
The company delivered a second-quarter earnings beat in late July, with earnings per share coming in ahead of consensus estimates and modestly ahead of the prior-year comparable period. Bank of America also lifted its price objective on Corteva shares during the year, maintaining a positive rating, which reflects a degree of underlying analyst confidence in the business. The dividend has been reaffirmed, and recent commentary has focused on the sustainability of cash generation relative to distributions.
Kalkine Media noted recently that several factors could shape the company’s next growth chapter, including its innovation pipeline in seed technology and ongoing efforts to manage cost headwinds. With the stock approaching the $90 level that BofA has previously highlighted, near-term price action will be worth watching closely. The three bear signals are a modest counterweight to today’s bullish technical reading and warrant vigilance.
4. CVS Health (CVS) – 13 technical buy signals
Price: $97.60 (+3.93% on the day)
View the full technical analysis of CVS Health
CVS Health matches the top bull-signal count with 13 and, like Cencora, registers zero bear signals — making it one of only two stocks in today’s list with a clean technical slate. The vertically integrated healthcare company, which spans pharmacy retail, pharmacy benefits management, and health insurance through Aetna, posted a strong daily gain of nearly 4%. The breadth of its technical strength across indicators adds weight to the signal.
The fundamental picture for CVS has been somewhat mixed in recent months. The stock outperformed the S&P 500 meaningfully over a six-month window, but subsequently pulled back more than 12% over a one-month period, according to recent reporting. This kind of volatility is not unusual for a large, complex healthcare conglomerate navigating regulatory scrutiny, a settlement related to insulin pricing with the FTC, and an evolving competitive landscape in pharmacy and insurance.
More constructively, the company raised its guidance earlier in the summer and announced an expanded focus on weight-management services — a growing area of healthcare demand. Seeking Alpha recently characterised CVS as a discounted healthcare business with a defensible integrated model. Today’s clean technical score may indicate that the recent pullback has run its course in the eyes of the market, though investors should remain attentive to ongoing developments in the regulatory environment.
5. Apple (AAPL) – 12 technical buy signals
Price: $325.13 (+2.61% on the day)
View the full technical analysis of Apple
Apple rounds out today’s top five with 12 bull signals against four bear signals. While that ratio is slightly less decisive than the other names on this list, Apple’s inclusion is notable for a reason that goes well beyond technical analysis: the company formally announced a CEO transition on 1 September 2026, with John Ternus succeeding Tim Cook at the helm. The stock rose sharply on the news, with the market appearing to take the leadership change in stride — at least in the near term.
Tim Cook’s 15-year tenure transformed Apple into one of the most valuable companies in the world, and Ternus, a long-serving Apple executive best known for his leadership of hardware engineering, inherits a business with a robust product ecosystem, substantial services revenue, and a loyal global customer base. His first major public test as CEO is expected within days of taking office, which adds an element of short-term event risk to the technical picture.
The four bear signals in today’s reading are worth keeping in mind, particularly given that the stock’s price surge appears to be directly linked to a single catalyst — the leadership announcement — rather than to a broad-based technical breakout. Investors considering this signal should be aware that headline-driven moves can be volatile and may not always sustain momentum once the initial reaction fades. Monitoring how the stock behaves in the sessions following the announcement will be informative.
Disclaimer: This blog post is produced for informational and educational purposes only and does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. Technical signals reflect historical price and volume data and are not predictive of future performance. All investments carry risk, including the possible loss of principal. Readers should conduct their own due diligence and consult a qualified financial adviser before making any investment decisions. The Wall Street Stock Investors Club does not hold positions in the securities mentioned and receives no compensation from any of the companies discussed.